Case report

RTMS in combination with aripiprazole and sodium valproate for the maintenance treatment of rapid cycling bipolar disorder

Datos Bibliográficos

ID15519561
AutoresSiyi Tao (0000-0002-3822-8057, First Affiliated Hospital Zhejiang University), Bing Chen (0000-0002-6058-9529, First Affiliated Hospital Zhejiang University), Xiaofang Xu (0009-0001-6319-8988, First Affiliated Hospital Zhejiang University), Shaohua Hu (0000-0003-0570-670X, First Affiliated Hospital Zhejiang University, autor de correspondencia), Jing Lü (0000-0001-5766-2775, First Affiliated Hospital Zhejiang University, autor de correspondencia)
Año2023
Volumen14
Páginas1070046-1070046
Fecha de publicación2023-03-16
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaFrontiers in Psychiatry (JOURNAL)
Identificadores de la revistaISSN: 1664-0640 • E-ISSN: 1664-0640
EditorialFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2023.1070046
PMID37009128
OpenAlexW4327615607
IdiomaEN
Referencias citadas22

As a safe neuromodulation therapy, rTMS is applied to treat a variety of psychiatric and neurological disorders. Additionally, both aripiprazole and sodium valproate are effective in the treatment of rapid cycling bipolar disorder. This case reports a female patient with a 17-year history of bipolar disorder who developed rapid-circulation bipolar disorder 5 years prior to presentation. After combined treatment with rTMS, aripiprazole, and sodium valproate, the patient's mood remained stable and she was able to live and work normally

Aripiprazole · Bipolar disorder · Bipolar I disorder · Carbamazepine · Epilepsy · Mania · Mood · Mood stabilizer · Psychiatry · Rapid cycling · Schizophrenia (object-oriented programming · Treatment of bipolar disorder · Bipolar Disorder and Treatment · Electroconvulsive Therapy Studies · Medicine · Neurological disorders and treatments · Psychology